DE VITO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.196
SA - Sud America 1.086
AS - Asia 1.026
EU - Europa 758
AF - Africa 59
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 4
Totale 4.134
Nazione #
US - Stati Uniti d'America 1.138
BR - Brasile 997
SG - Singapore 516
IT - Italia 246
HK - Hong Kong 217
DE - Germania 195
FI - Finlandia 105
CN - Cina 102
UA - Ucraina 42
TR - Turchia 31
AR - Argentina 29
RU - Federazione Russa 26
CZ - Repubblica Ceca 24
BD - Bangladesh 21
VE - Venezuela 21
CA - Canada 20
MX - Messico 19
GB - Regno Unito 18
IQ - Iraq 18
EC - Ecuador 17
MA - Marocco 17
KR - Corea 16
AT - Austria 15
UZ - Uzbekistan 15
PK - Pakistan 13
ZA - Sudafrica 13
BE - Belgio 10
RO - Romania 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
TN - Tunisia 8
AZ - Azerbaigian 7
CO - Colombia 7
IE - Irlanda 7
JM - Giamaica 7
PS - Palestinian Territory 7
RS - Serbia 7
UY - Uruguay 7
JO - Giordania 6
KG - Kirghizistan 6
LT - Lituania 6
EG - Egitto 5
HU - Ungheria 5
KE - Kenya 5
SE - Svezia 5
AU - Australia 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
FR - Francia 4
IN - India 4
NL - Olanda 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
AM - Armenia 3
GE - Georgia 3
GR - Grecia 3
ID - Indonesia 3
KZ - Kazakistan 3
NP - Nepal 3
PA - Panama 3
PE - Perù 3
BN - Brunei Darussalam 2
BY - Bielorussia 2
CH - Svizzera 2
CI - Costa d'Avorio 2
CL - Cile 2
DZ - Algeria 2
ES - Italia 2
HN - Honduras 2
JP - Giappone 2
LU - Lussemburgo 2
MK - Macedonia 2
MT - Malta 2
MZ - Mozambico 2
NI - Nicaragua 2
OM - Oman 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
KW - Kuwait 1
LB - Libano 1
MD - Moldavia 1
ML - Mali 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PT - Portogallo 1
SA - Arabia Saudita 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.134
Città #
Chandler 345
Singapore 289
Hong Kong 214
New York 179
Munich 131
Helsinki 91
Princeton 68
Sassari 61
São Paulo 58
Shanghai 52
Belo Horizonte 37
Rio de Janeiro 37
Brasília 26
Boardman 25
Brno 24
Santa Clara 24
Ashburn 21
Rome 20
Curitiba 16
Seoul 16
Wilmington 16
Falkenstein 15
Nuremberg 15
Fortaleza 14
Tashkent 12
Alghero 10
Brussels 10
Dallas 10
Guarulhos 10
Porto Alegre 10
Romola 10
Salvador 10
Toronto 10
Baghdad 9
Campinas 9
Jacksonville 9
Ribeirão Preto 9
Cagliari 8
Florianópolis 8
Istanbul 8
Mountain View 8
Ottawa 8
Recife 8
Sorocaba 8
São José dos Campos 8
Duque de Caxias 7
Frankfurt am Main 7
Ipatinga 7
João Pessoa 7
Lappeenranta 7
Nova Iguaçu 7
Santo André 7
São Luís 7
Turin 7
Uberlândia 7
Amman 6
Baku 6
Barbianello 6
Bishkek 6
Cape Town 6
Contagem 6
Dublin 6
Feira de Santana 6
Goiânia 6
Guayaquil 6
Vienna 6
Ankara 5
Ann Arbor 5
Barbacena 5
Caracas 5
Caruaru 5
Casablanca 5
Council Bluffs 5
Cuiabá 5
Dhaka 5
Florence 5
Lahore 5
London 5
Nairobi 5
Osasco 5
Piracicaba 5
Santa Maria 5
São Bernardo do Campo 5
Tel Aviv 5
Tunis 5
Volta Redonda 5
Washington 5
Alvorada 4
Americana 4
Andover 4
Belgrade 4
Betim 4
Campo Grande 4
Falls Church 4
Guangzhou 4
Joinville 4
Jundiaí 4
Jyväskylä 4
Kingston 4
Marília 4
Totale 2.279
Nome #
How Little Do We Know about HIV and STIs Prevention? Results from a Web-Based Survey among the General Population 182
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 92
A case of vasculitis-like skin eruption associated with COVID-19 85
Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases 84
Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study 83
Clinical features, laboratory findings and predictors of death in hospitalized patients with COVID-19 in Sardinia, Italy 81
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 80
The De Ritis ratio as prognostic biomarker of in-hospital mortality in COVID-19 patients 76
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 76
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 70
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 68
Bone safety of dolutegravir-containing regimens in people living with HIV: Results from a real-world cohort 65
Correlations between IL-6 serum level and olfactory dysfunction severity in COVID-19 patients: a preliminary study 64
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 61
High-risk sexual behavior and HIV/STDs cascade of care in migrants: Results from an Italian dedicated outpatient clinic 59
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 59
Coronavirus disease 2019 (COVID-19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus-2 (SARS-CoV-2) Omicron variant 59
Use of bedaquiline in spinal osteomyelitis and soft tissue abscess caused by multidrug-resistant Mycobacterium tuberculosis: A case report 58
Chronic viral hepatitis in the italian prison setting: Prevalence, outcomes, literature needs and perspectives 57
Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation? 57
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 57
HIV Infection Indicator Disease-Based Active Case Finding in a University Hospital: Results from the SHOT Project 56
Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience 55
Efficacy and safety of dolutegravir-based regimens in advanced HIV-infected naïve patients: results from a multicenter cohort study 55
Editorial - HIV and cancer during COVID-19 pandemic: Sailing through the perfect storm 55
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 54
Severity of lung involvement on chest x-rays in sars-coronavirus-2 infected patients as a possible tool to predict clinical progression: An observational retrospective analysis of the relationship between radiological, clinical, and laboratory data 52
Circulation of SARS-CoV-2 Among Asylum Seekers: A Real-Life Experience to Address Health Equity in Piacenza, Italy 50
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 49
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 49
Early combination treatment with existing HIV antivirals: An effective treatment for COVID-19? 49
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 49
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 48
Reduced risk of death in people with SARS-CoV-2 infection treated with remdesivir: a nested case-control study 47
Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort 47
Vaccination and anti-SARS-CoV-2 treatment reduce disease progression: a real-life experience 47
The The PaO2/FiO2 ratio on admission is independently associated with prolonged hospitalization in COVID-19 patients 47
Vaccination and Antiviral Treatment Reduce the Time to Negative SARS-CoV-2 Swab: A Real-Life Study 46
Has COVID-19 changed the approach to HIV diagnosis?: A multicentric Italian experience 45
Safety and efficacy of molnupiravir in SARS-CoV-2-infected patients: A real-life experience 44
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects 43
Human urogenital schistosomiasis in West and Sub-Saharan Africa migrants in Sardinia, Italy: A retrospective monocentric study 43
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 42
What do We Know about Cryptic Aspergillosis? 40
Mood Reactive Disorders among COVID-19 Inpatients: Experience from a Monocentric Cohort 40
Infectious diseases screening approach among refugees: Results from a single-center study 40
Quick diagnostic approach for HIV/STDs among migrants: results from a monocentric Italian cohort 39
New score to predict COVID-19 progression in vaccine and early treatment era: the COVID-19 Sardinian Progression Score (CSPS) 39
The current and future off-label uses of dalbavancin: a narrative review 39
Assessing ChatGPT’s Potential in HIV Prevention Communication: A Comprehensive Evaluation of Accuracy, Completeness, and Inclusivity 39
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 38
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 38
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 38
HBV in Italian Women’s Jail: An Underestimated Problem? 37
Quick diagnosis, staging, and treatment of HCV infection among people living in prison: Opinion expert panel 36
Recovery from olfactory and gustatory dysfunction following COVID-19 acquired during Omicron BA.1 wave in Italy 36
Facing HCV as a Major Public Healthcare Threat in Italy: Epidemiology and Micro-Elimination Pathways among Underserved Populations 35
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 35
Resistance in Pseudomonas aeruginosa: A Narrative Review of Antibiogram Interpretation and Emerging Treatments 35
Sexually Transmitted Infections Prevalence and Cascade of Care among Undocumented Sex Workers: A Twenty-Year-Long Experience 35
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes 34
Risk of COVID-19 in-hospital mortality in people living with HIV compared to general population according to age and CD4 strata: data from the ICONA network 33
Knowledge of Sexually Transmitted Infections and HIV among People Living with HIV: Should We Be Concerned? 33
Impact of Early SARS-CoV-2 Antiviral Therapy on Disease Progression 33
Women Living with HIV in Italian Prison Settings: Results from the Gender-Specific ROSE Network 33
Early versus delayed antiretroviral therapy based on genotypic resistance test: Results from a large retrospective cohort study 32
Is the 4C Score Still a Valid Item to Predict In-Hospital Mortality in People with SARS-CoV-2 Infections in the Omicron Variant Era? 32
The high burden of pediatric cystic echinococcosis in Kazakhstan: epidemiological and clinical consequences 31
Emerging Clinical Features of COVID-19 Related Pancreatitis: Case Reports and Review of the Literature 31
New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature 31
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 30
What Is the Efficacy of Sotrovimab in Reducing Disease Progression and Death in People with COVID-19 during the Omicron Era? Answers from a Real-Life Study 30
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 30
Knowledge, Attitudes, and Practices toward Antimicrobial Resistance among Young Italian Nurses and Students: A Multicenter, Cross-Sectional Study 29
Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy: Much More Than a Positive Finding 29
Special Issue "Efficacy and Safety of Antiviral Therapy" 28
Time spent with HIV-RNA ≤ 200 copies/ml in a cohort of people with HIV during the U=U era 28
SARS-CoV-2 Vaccination Among Incarcerated People: A Barrier to Overcome 28
null 28
Reply letter - “Safety and efficacy of oral lopinavir/ritonavir in pediatric patients with coronavirus disease: A nationwide comparative analysis” 28
Living with HIV and Getting Vaccinated: A Narrative Review 28
Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors: A retrospective cohort study 27
Viral Hepatitis C New Microelimination Pathways Objective: Psychiatric Communities HCV Free 27
In Response to Smell and Taste Loss in COVID-19 After Complete Vaccination: Correspondence 27
Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen 25
Shedding new light on COVID-19 therapeutics during the omicron era: a deeper dive into real-world data 25
Viro-Immunological Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide among Women Living with HIV: A 96-Week Post-Switch Analysis from the Real-Life SHiNe-SHiC Cohort 24
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 24
Perspectives on climate action and the changing burden of infectious diseases among young Italian doctors and students: a national survey 24
Incidence and burden of long COVID in Africa: a systematic review and meta-analysis 24
New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination 23
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 23
Switching from tenofovir disoproxil fumarate to tenofovir alafenamide or dual therapy-based regimens in HIV-infected individuals with viral load ≤50 copies/mL: does estimated glomerular filtration rate matter? 22
Treatment Experienced People Living With HIV switching to DOR/3TC/TDF in Outpatient Setting: Real-World Data on Tolerability and Cost Savings From an Italian Multicenter Cohort 21
Efficacy and Safety of Ceftazidime–Avibactam Alone versus Ceftazidime–Avibactam Plus Fosfomycin for the Treatment of Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: A Multicentric Retrospective Study from the SUSANA Cohort 20
Enhancing AI Chatbot Responses in Health Care: The SMART Prompt Structure in Head and Neck Surgery 18
Totale 4.277
Categoria #
all - tutte 24.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.924


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 0 0 0 0 1 0 4 0
2020/2021138 2 3 14 0 9 16 10 23 44 17 0 0
2021/2022177 4 4 5 1 1 4 1 5 8 18 41 85
2022/2023646 44 74 20 96 47 97 25 80 97 15 39 12
2023/2024535 38 28 20 27 194 92 4 7 2 5 34 84
2024/20252.772 50 36 183 137 161 155 392 653 1.005 0 0 0
Totale 4.277